Leukemia Research Journal Citation Rate 2026
0145-2126
eISSN 1873-5835
Elsevier BV
GB
Q3 Quartile
About Leukemia Research
Leukemia Research (LR) is a peer-reviewed academic journal covering Acute Lymphoblastic Leukemia research and Acute Myeloid Leukemia Research, published by Elsevier BV in GB, catalogued under ISSN 0145-2126 (e-ISSN 1873-5835). As of 2026, it has a 2025 2-Year Citation Rate (OpenAlex) of 0.85 (Q3 quartile) — the average number of citations its recent articles received over a two-year window, computed from OpenAlex open citation data, not the Clarivate (JCR) Impact Factor. It operates a subscription model (APC ~$4050 USD). OpenAlex records 13,663 works and 182,663 citations, with an h-index of 118.
Leukemia Research Citation Rate 2026 — In Context
Leukemia Research has a 2025 2-Year Citation Rate (OpenAlex) of 0.85, placing it in the Q3 quartile within the Acute Lymphoblastic Leukemia research research area. This is the average number of citations the journal's recent articles received over a two-year window, computed from OpenAlex open citation data — not the Clarivate (JCR) Journal Impact Factor.
Leukemia Research operates a subscription-based publishing model — readers access articles through institutional subscriptions or pay-per-view.
Researchers looking to publish in Leukemia Research should review the journal's submission tips and verify the latest indexing status against Scopus, DOAJ, and Web of Science using our indexing tracker. To compare Leukemia Research against similar journals in the field, use our journal comparison tool.
Submission Tips for Leukemia Research
- Budget $4050 for the Article Processing Charge. Check if your institution or funder covers OA fees.
- This journal covers Acute Lymphoblastic Leukemia research, Acute Myeloid Leukemia Research, Chronic Lymphocytic Leukemia Research. Ensure your manuscript aligns with these scope areas to avoid desk rejection.
How Leukemia Research Compares
Compared against 22 journals in the same research areas.
| ISSN (Print) | 0145-2126 |
|---|---|
| ISSN (Online) | 1873-5835 |
| Publisher | Elsevier BV |
| Country | United Kingdom |
| APC / Cost | $4050 USD |
In-depth profile & metrics
Leukemia Research is published by Elsevier BV and based in United Kingdom. It runs on a subscription or hybrid model with an article-processing charge of USD 4050.
In our subject taxonomy, Leukemia Research is classified under Acute Lymphoblastic Leukemia research, Acute Myeloid Leukemia Research, Chronic Lymphocytic Leukemia Research and Chronic Myeloid Leukemia Treatments.
Leukemia Research is indexed in OpenAlex. OpenAlex tracking provides an open, citable record of its output even where commercial indexing is absent.
Its most recent citation rate stands at 0.850.
Research Areas
Links
Continue on JournalsHub
Put what you just read into practice with these free tools.
Frequently Asked Questions about Leukemia Research
Live Indexing Status
Updated April 2026Track real-time indexing metrics to ensure this journal meets your academic requirements.
Citation Rate
Historical Trend
Initial data points onlyCitation Rate by Year
| Year | Value | Source |
|---|---|---|
| 2025 | 0.850 | 2-Year Mean Citedness (OpenAlex) |
Metrics are sourced from OpenAlex, DOAJ and Scopus and reflect the latest data we hold. The headline figure is a 2-year citation rate (OpenAlex), not a Clarivate Impact Factor. Always verify against the journal's official site before relying on it. See our Methodology or report a correction.
Compare Journals
Compare Leukemia Research against similar publications in its field:
Related Journals in Your Field
-
Modern Pathology Elsevier BV IF 5.84
-
Leukemia Springer Nature IF 5.73
-
American Journal of Hematology Wiley IF 4.50
-
Blood Advances Elsevier BV IF 4.44
-
Bone Marrow Transplantation Springer Nature IF 2.73
Explore More Journals
Metadata
Last updated: Apr 24, 2026
Updated by: openalex_bulk
OpenAlex ID: S136942575
Get weekly updates for Acute Lymphoblastic Leukemia research journals
Free. Monday morning. New citation rates, CFPs, indexing alerts, predatory watch list. One-click unsubscribe.